A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC

NCT03601598 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

41

Enrollment

OTHER

Sponsor class

Conditions

CRC
HCC
NSCLC

Interventions

DRUG: SHR-1210
DRUG: SHR6390

Sponsor

Harbin Medical University

Collaborators

[object Object]